106. Cryopyrin-associated periodic syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 42 / Drugs : 24 - (DrugBank : 4) / Drug target genes : 4 - Drug target pathways : 48
Cryopyrin-associated periodic syndrome and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
| ID | Diseases (Sorted by drug repositionability) |
|---|---|
| 106 | Cryopyrin-associated periodic syndrome |
| 266 | Familial mediterranean fever |
| 13 | Multiple sclerosis/Neuromyelitis optica |
| 46 | Malignant rheumatoid arthritis |
| 84 | Sarcoidosis |
| 50 | Dermatomyositis |
| 107 | Juvenile idiopathic arthritis |
| 41 | Giant cell arteritis |
| 56 | Behcet disease |
| 15 | Inclusion body myositis |
| 37 | Generalised pustular psoriasis |
| 228 | Bronchiolitis obliterans |
| 164 | Oculocutaneous albinism |
| 58 | Hypertrophic cardiomyopathy |
| 222 | Primary nephrotic syndrome |
| 28 | Systemic amyloidosis |
| 19 | Lysosomal storage disease |
| 34 | Neurofibromatosis |
| 65 | Primary immunodeficiency |
| 299 | Cystic fibrosis |
| 85 | Idiopathic interstitial pneumonia |
| 86 | Pulmonary arterial hypertension |
| 51 | Scleroderma |
| 49 | Systemic lupus erythematosus |
| 97 | Ulcerative colitis |
| 2 | Amyotrophic lateral sclerosis |
| 108 | TNF receptor-associated periodic syndrome |
| 267 | Hyper-IgD syndrome |